Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemical modification of steffimycin B.

P F Wiley1, D W Elrod, D E Harper

  • 1Research Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.

The Journal of Antibiotics
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do signs of an effusion of the temporomandibular joint on magnetic resonance imaging correlate with signs and symptoms of temporomandibular joint disease?

The British journal of oral & maxillofacial surgery·2018
Same author

Conditioned pain modulation dampens the thermal grill illusion.

European journal of pain (London, England)·2017
Same author

Pain Mechanisms and Centralized Pain in Temporomandibular Disorders.

Journal of dental research·2016
Same author

Prediction of membrane protein types and subcellular locations.

Proteins·1999
Same author

Protein subcellular location prediction.

Protein engineering·1999
Same author

Using discriminant function for prediction of subcellular location of prokaryotic proteins.

Biochemical and biophysical research communications·1998
Same journal

Pheophorbide a from Acrotrema agastyamalayanum: A potent antibiofilm agent targeting Proteus mirabilis.

The Journal of antibiotics·2026
Same journal

Tsukubacyclinone, a novel angucyclinone compound with anti-inflammatory activity in synovial cell line SW982, produced by Streptomyces sp. K21-0141.

The Journal of antibiotics·2026
Same journal

Macrolide antibiotic action, resistance, and tolerance, and approaches to improve their activity against Gram-negative bacteria.

The Journal of antibiotics·2026
Same journal

Activation of hamiformamide production in the thermotolerant fungus Hamigera avellanea triggered by co-culture with animal immune cells.

The Journal of antibiotics·2026
Same journal

Biosynthesis and enzymology of azaindane natural products.

The Journal of antibiotics·2026
Same journal

Inhibition of Proteus mirabilis growth through gallium-based disruption of iron and heme metabolism.

The Journal of antibiotics·2026
See all related articles

Researchers synthesized 15 new steffimycin B analogues. Three analogues showed significantly higher activity against P388 murine leukemia than the original compound, indicating potential for improved cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Steffimycin B is an anthracycline antibiotic with known cytotoxic properties.
  • Anthracyclines are a critical class of anticancer agents used in chemotherapy.
  • Developing novel analogues can overcome resistance and improve therapeutic indices.

Purpose of the Study:

  • To synthesize and evaluate novel 3-substituted analogues of steffimycin B.
  • To identify analogues with enhanced anticancer activity against P388 murine leukemia.
  • To explore structure-activity relationships for steffimycin B derivatives.

Main Methods:

  • Synthesis of fifteen 3-substituted analogues of steffimycin B.
  • In vitro evaluation of compound cytotoxicity using the P388 murine leukemia cell line.

Related Experiment Videos

  • Comparative analysis of analogue activity against the parent compound.

    • Main Results:

    • Fifteen novel steffimycin B analogues were successfully synthesized.
    • Three analogues demonstrated substantially greater cytotoxic activity compared to steffimycin B.
    • These findings highlight specific structural modifications that enhance antileukemic potency.

    Conclusions:

    • The synthesized 3-substituted analogues represent promising leads for new anticancer drug development.
    • Further investigation of these potent analogues is warranted for potential clinical application.
    • Structure-activity relationship studies can guide the design of more effective steffimycin B-based chemotherapeutics.